Search

Your search keyword '"Hernández-Blasco, L."' showing total 232 results

Search Constraints

Start Over You searched for: "Hernández-Blasco, L." Remove constraint "Hernández-Blasco, L." Language english Remove constraint Language: english
232 results on '"Hernández-Blasco, L."'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

3. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

4. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

5. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

6. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

7. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

8. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

9. Timing and characteristics of venous thromboembolism after noncancer surgery

10. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

11. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

12. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

13. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

14. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

15. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

16. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

17. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

18. Venous thromboembolism (VTE) developing after ankle sprain. Comparison with VTE after knee arthroplasty.

19. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

20. DVT Management and Outcome Trends, 2001 to 2014

21. A prognostic score to identify low‐risk outpatients with acute deep vein thrombosis in the upper extremity

22. Transcriptomic Profiling of Pleural Effusions: Differences in Malignant and Infectious Fluids.

23. Radiological usual interstitial pneumonia pattern is associated with two-year mortality in patients with idiopathic pulmonary fibrosis.

24. Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?

25. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

26. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

27. Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study.

29. Comparison of Presentation, Treatment, and Outcomes of Venous Thromboembolism in Long-Term Immobile Patients Based on Age.

31. First evidence of microplastics isolated in European citizens' lower airway.

33. Mosaic attenuation in non-fibrotic areas as a predictor of non-usual interstitial pneumonia pathologic diagnosis.

34. Prognostic Impact of Active Cigarette Smoking on Mortality in Patients with Acute Venous Thromboembolic Events, Findings from Real World Data.

35. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial).

36. Proangiogenic factor midkine is increased in melanoma patients with sleep apnea and induces tumor cell proliferation.

37. Psychotropic Drugs and Outcome in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.

38. Soluble PD-L1 is a potential biomarker of cutaneous melanoma aggressiveness and metastasis in obstructive sleep apnoea patients.

39. Intermittent Hypoxia Is Associated With High Hypoxia Inducible Factor-1α but Not High Vascular Endothelial Growth Factor Cell Expression in Tumors of Cutaneous Melanoma Patients.

40. A prospective multicenter cohort study of cutaneous melanoma: clinical staging and potential associations with HIF-1α and VEGF expressions.

41. Therapeutic decision-making for sleep apnea and hypopnea syndrome using home respiratory polygraphy: a large multicentric study.

42. Gender differences in cancer patients with acute venous thromboembolism.

43. Mobile Sleep Lab: Comparison of polysomnographic parameters with a conventional sleep laboratory.

44. Challenges in Obstructive Sleep Apnea Management in Elderly Patients.

46. Airborne Microplastics: Challenges, Prospects, and Experimental Approaches.

47. Microplastics in the Human Body: Exposure, Detection, and Risk of Carcinogenesis: A State-of-the-Art Review.

48. Effectiveness of three sleep apnea management alternatives.

49. Effectiveness of sequential automatic-manual home respiratory polygraphy scoring.

50. Significance of including a surrogate arousal for sleep apnea-hypopnea syndrome diagnosis by respiratory polygraphy.

Catalog

Books, media, physical & digital resources